US4745131A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Amidinoureas for treating irritable bowel syndrome
Assignee: Aventis Pharmaceuticals Inc
•
Filing: 1986-06-12
•
Granted: 1988-05-17
•
Expires: 2006-06-12
Abstract
Abstract 1-Phenyl-3N-alkyl amidinoureas are useful in the treatment of Irritable Bowel Syndrome.
Inventors
- 👤 John Yelnosky
- 👤 Ghulam N. Mir
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-31 00:49
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/16; A61K31/17
Claims Analysis
Total Claims: 2
Claim 1
Independent Claim
47 words
A method for the treatment of irritable bowel syndrome in a constipated patient comprising administering to said patient, one to eight times daily, an anticonstipating effective oral or parenteral dose of about 0.05 to about 10 mg of 1-(2,6-dimethylphenyl)-3-N-methyl-amidinourea or a pharmaceutically acceptable acid addition salt thereof.
Claim 2
Independent Claim
47 words
A method for the treatment of irritable bowel syndrome in a constipated patient comprising administering to said patient, one to eight times daily, an anticonstipating effective oral or parenteral dose of about 0.05 to about 10 mg of 1-(2,6-dimethylphenyl)-3-N-methyl-amidinourea or a pharmaceutically acceptable acid addition salt thereof.
References Cited (Backward Citations)
US4147804A
Cited
US4239768A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1991-05-17 | 1991-11-16 | 1992-05-17 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1995-05-17 | 1995-11-16 | 1996-05-17 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1999-05-17 | 1999-11-16 | 2000-05-17 | $7700.00 | Window Closed / Lapsed |